SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-18-000162
Filing Date
2018-11-08
Accepted
2018-11-08 16:04:39
Documents
51
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20180930.htm   iXBRL 10-Q 1431784
2 EXHIBIT 31.1 lgnd93018exhibit311-ne.htm EX-31.1 20940
3 EXHIBIT 31.2 lgnd93018exhibit312-ne.htm EX-31.2 21270
4 EXHIBIT 32.1 lgnd93018exhibit321-ne.htm EX-32.1 15955
  Complete submission text file 0000886163-18-000162.txt   6395286

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20180930.xsd EX-101.SCH 32430
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20180930_cal.xml EX-101.CAL 75796
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20180930_def.xml EX-101.DEF 211005
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20180930_lab.xml EX-101.LAB 500684
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20180930_pre.xml EX-101.PRE 320027
10 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20180930_htm.xml XML 1243332
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 181169648
SIC: 2834 Pharmaceutical Preparations